Tatiana Holder Novelo turned a ‘no cure’ diagnosis into a mission that is now changing lives and redefining medicine’s limits.
Tatiana Holder Novelo has spent much of her life battling multiple debilitating conditions: Ehlers-Danlos Syndrome (EDS), Dysautonomia, Postural Orthostatic Tachycardia Syndrome (POTS), Hypoglycemia, Polycystic Ovary Syndrome (PCOS), and Mast Cell Activation Syndrome (MCAS). For most, the diagnosis of these chronic conditions could signal a life of constant pain, frustration, and minimal treatment options. Yet, for Tatiana, these same diagnoses sparked a determination to challenge the limitations imposed by the medical community.
Instead of accepting a future defined by symptom management and “no cure,” Tatiana decided to take control of her health. She became the first patient, “Patient One,” in her own company, Neorgana, a regenerative medicine firm she co-founded with her husband, CEO Omar Novelo Medina. Through Neorgana, Tatiana is not only pursuing innovative treatments for herself but is also providing a glimmer of hope for others who are suffering from similar conditions.
From Adversity to Innovation: Tatiana’s Story
Tatiana’s journey has been anything but simple. Growing up with EDS, she was all too familiar with the crippling pain, instability, and fatigue that came with joint and tissue complications. Add to this the unpredictable nature of POTS, a condition that disrupts the body’s regulation of heart rates and blood pressure, and the impact of MCAS, which causes frequent allergic reactions and systemic inflammation, and it becomes clear why many in Tatiana’s shoes might feel helpless.
For years, the treatment options for these conditions were limited to symptom management, medications, lifestyle adjustments, and therapies that did little to address the root causes. But Tatiana’s experience with chronic illness was about to take a radical turn.
“I realized that if no one else was going to create solutions for people like me, then I would,” Tatiana recalls. Her frustration and resolve birthed the idea for Neorgana, a company focused on developing regenerative medicine treatments that go beyond traditional methods and instead aim to repair and restore the body at a cellular level.
Neorgana: A Vision Powered by Empathy and Science
Neorgana was founded on the belief that the medical field can do more than simply manage chronic illnesses, it can transform them. By combining advanced regenerative treatments with a human-centered approach, Neorgana’s goal is to repair the body’s foundational structures and regenerate damaged tissues. But this mission isn’t just driven by theoretical research, it’s personal.
Tatiana’s decision to be “Patient One” was not a mere symbolic gesture. It was a powerful statement of her belief in the efficacy of Neorgana’s treatments. By undergoing the first treatment herself, Tatiana showed the world that healing is not just a dream but a reality that can be built with the right science, empathy, and determination.
Her mantra, “What the world considers incurable might just be undiscovered,” reflects her deep-rooted commitment to uncovering new, cutting-edge solutions for chronic diseases that have long been deemed untreatable.
Omar Novelo Medina: Leading the Charge with Innovation
While Tatiana is the heart of Neorgana, her husband, Omar Novelo Medina, is the driving force behind the company’s scientific and technological advancements. As the CEO, Omar’s strategic leadership has been instrumental in turning Neorgana’s vision into reality. His ability to bridge the gap between groundbreaking biomedical research and its practical application has enabled Neorgana to offer transformative therapies that were once thought impossible.
Omar’s leadership extends beyond managing the company’s operations. He is passionate about forging partnerships with scientists, researchers, and biomedical product developers from around the world to ensure that Neorgana’s treatments are always at the forefront of medical innovation. His focus on scaling the company’s mission is as much about making regenerative medicine accessible as it is about ensuring it is scientifically sound and effective.
“Tatiana brings lived experience and courage, while Omar ensures that vision is scaled with science and technology,” says a colleague from Neorgana. Together, their combined efforts create a synergy that is both emotionally compelling and scientifically robust.
Leading by Example: Tatiana as “Patient One”
Tatiana’s decision to undergo Neorgana’s treatment as the first patient was more than an act of bravery, it was an embodiment of true leadership. In the face of uncertainty, she chose to trust the very process that she and her husband had worked so hard to develop. Her willingness to be the first to try the therapy gave a sense of purpose to Neorgana’s mission and sent a message of hope to others battling chronic conditions.
For many patients, watching Tatiana’s journey has been transformative in itself. She represents the possibility that the “no cure” diagnosis does not have to be the end of the road. As she progresses through her treatments, every milestone serves as a beacon of hope for those who have spent years struggling with conditions like EDS, POTS, MCAS, and others.
Breaking the “Incurable” Narrative
The medical community has long resigned itself to the idea that some chronic illnesses are simply “incurable.” For years, patients have been forced to accept that there is little more than symptom management available. But Neorgana is challenging this narrative head-on. Through the use of regenerative medicine, the company is pushing boundaries and offering a new way forward, one that focuses not just on masking symptoms but on healing the body at its core.
Omar Novelo Medina’s leadership in integrating advanced research with practical applications has set Neorgana apart. Under his guidance, Neorgana is reshaping the way chronic diseases are viewed and treated. Rather than relying on conventional methods that offer little more than temporary relief, Neorgana’s treatments aim to restore function and health at a cellular level, offering real solutions for long-term healing.
Neorgana’s Future: Hope on the Horizon
Though Neorgana’s journey is still in its early stages, the company’s progress has already begun to make waves in the world of regenerative medicine. For Tatiana, each treatment milestone is not just a personal victory, it’s a step toward proving that healing is possible. For Omar, every technological breakthrough brings them closer to scaling the company’s impact and making these innovative therapies accessible to a wider audience.
Together, Tatiana and Omar Novelo are not just pushing the boundaries of science, they are creating a new chapter in the treatment of chronic illnesses. And they are doing so with empathy, courage, and the unwavering belief that “incurable” is not the end; it’s merely the beginning of a new story in medicine.
